are glp-1 specialty drugs Insights from Physicians on GLP-1RA Medications Off-Label Use Addressing GLP-1 Access and Adherence
Description
Both involve subcutaneous needles, dosing schedules, and pharmacy conversations that sound remarkably similar
Taylor K et al
doi: 10.17219/acem/121007 119 ChenTTianPHuangZZhaoXWangHXiaCet al
The primary endpoint is change in DAS28-CRP at week 12, a validated measure of RA disease activity
Soluble CD26/dipeptidyl peptidase IV enhances transendothelial migration via its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
